Geode Capital Management, LLC Vivos Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.35 - $20.75 $162 - $9,628	-464 Reduced 0.23%	201,941 $81,000
Q2 2022 Aug 12, 2022	BUY	$1.12 - $2.18 $735 - $1,432	657 Added 0.33%	202,405 $261,000
Q1 2022 May 13, 2022	BUY	$1.63 - $3.63 $147,164 - $327,734	90,285 Added 81.0%	201,748 $540,000
Q4 2021 Feb 11, 2022	BUY	$2.25 - $4.11 $84,627 - $154,585	37,612 Added 50.93%	111,463 $250,000
Q3 2021 Nov 12, 2021	BUY	$2.71 - $5.9 $70,974 - $154,521	26,190 Added 54.95%	73,851 $298,000
Q2 2021 Aug 13, 2021	BUY	$4.83 - $9.67 $170,407 - $341,167	35,281 Added 284.98%	47,661 $235,000
Q1 2021 May 12, 2021	BUY	$6.01 - $8.9 $74,403 - $110,182	12,380 New	12,380 $82,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.